Evidence map›Paper›PMID 29370175›Full record

ArticlePLoS genetics2018

Genomic locus modulating corneal thickness in the mouse identifies POU6F2 as a potential risk of developing glaucoma.

Rebecca King, Felix L Struebing, Ying Li, Jiaxing Wang, Allison Ashley Koch, Jessica N Cooke Bailey, Puya Gharahkhani, International Glaucoma Genetics Consortium, NEIGHBORHOOD Consortium, Stuart MacGregor and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Current Advancements in Mouse Models of Retinal Disease.Advances in experimental medicine and biology · 2023
    Article
  11. Frontiers in endocrinology · 2023
    Article
  12. Cell atlas of the human ocular anterior segment: Tissue-specific and shared cell types.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  13. Safety, efficacy and delivery of multiple nucleoside analogs via drug encapsulated carbon (DECON) based sustained drug release platform.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V · 2022
    Article
  14. Article
  15. Review
  16. Genetic control of retinal ganglion cell genesis.Cellular and molecular life sciences : CMLS · 2021
    Review
  17. Frontiers in bioengineering and biotechnology · 2021
    Article
  18. Cell atlas of aqueous humor outflow pathways in eyes of humans and four model species provides insight into glaucoma pathogenesis.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Rebecca KingDepartment of Ophthalmology, Emory University, Atlanta, Georgia, United States of America.ORCID 0000-0003-0874-0102
Felix L StruebingDepartment of Ophthalmology, Emory University, Atlanta, Georgia, United States of America.ORCID 0000-0002-9436-6294
Ying LiDepartment of Ophthalmology, Emory University, Atlanta, Georgia, United States of America.
Jiaxing WangDepartment of Ophthalmology, Emory University, Atlanta, Georgia, United States of America.
Allison Ashley KochDuke Molecular Physiology Institute, Duke University, Durham, North Carolina, United States of America.ORCID 0000-0001-5409-9155
Jessica N Cooke BaileyDepartment of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, United States of America.ORCID 0000-0002-4001-8702
Puya GharahkhaniStatistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID 0000-0002-4203-5952
International Glaucoma Genetics Consortium
NEIGHBORHOOD Consortium
Stuart MacGregorStatistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID 0000-0001-6731-8142
R Rand AllinghamDepartment of Medicine and Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States of America.
Michael A HauserDepartment of Medicine and Ophthalmology, Duke University Medical Center, Durham, North Carolina, United States of America.
Janey L WiggsDepartment of Ophthalmology, Harvard Medical School of Medicine, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States of America.
Eldon E GeisertDepartment of Ophthalmology, Emory University, Atlanta, Georgia, United States of America.
Emory University · USDuke Medical Center · USQIMR Berghofer Medical Research Institute · AUCase Western Reserve University · USDuke University · USMassachusetts Eye and Ear Infirmary · US

Funding

VISION RESEARCHP30EY005722 · NEI · DUKE UNIVERSITY · PI Vadim Y Arshavsky · 1985 to 2026
$19.3M
P30-Core Grant for Vision Research Core CP30EY006360 · NEI · EMORY UNIVERSITY · PI NICKERSON, JOHN M · 1986 to 2025
$15.3M
P30 Core Grant for Vision ResearchP30EY014104 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI Janey L Wiggs · 2002 to 2026
$15.1M
Clinical and Translational Science Collaborative of ClevelandKL2TR000440 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI KONSTAN, MICHAEL W. · 2012 to 2016
$11.1M
The NEIGHBORHOOD: POAG Heritable Overall Operational DatabaseR01EY022305 · NEI · MASSACHUSETTS EYE AND EAR INFIRMARY · PI WIGGS, JANEY L · 2012 to 2025
$7.9M
Gene Discovery in Familial KeratoconusR01EY023242 · NEI · DUKE UNIVERSITY · PI LIU, YUTAO · 2013 to 2023
$3.4M
Admixture Mapping of Glaucoma Genes in African AmericansR01EY019126 · NEI · DUKE UNIVERSITY · PI HAUSER, MICHAEL A · 2008 to 2012
$3.2M
Modulators of Retinal InjuryR01EY017841 · NEI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI GEISERT, ELDON E · 2007 to 2016
$3.0M
Molecular Genetics of Norma Tension GlaucomaR01EY023512 · NEI · UNIVERSITY OF IOWA · PI FINGERT, JOHN H, MULLINS, ROBERT FOSTER · 2014 to 2017
$1.8M
Gene Discovery in Primary Congenital GlaucomaR01EY023646 · NEI · DUKE UNIVERSITY · PI ALLINGHAM, ROBERT RAND, HAUSER, MICHAEL A · 2013 to 2015
$1.3M
Data commons for 'omic, microscopy and analysis core facilitiesS10OD018164 · OD · DUKE UNIVERSITY · PI WRAY, GREGORY A. · 2014 to 2014
$598k
Long Noncoding RNA lncLOXL1 and Exfoliation Syndrome.R21EY028671 · NEI · AUGUSTA UNIVERSITY · PI LIU, YUTAO · 2018 to 2019
$467k
NCATS NIH HHS KL2 TR000440NEI NIH HHS P30 EY005722NEI NIH HHS P30 EY006360NEI NIH HHS P30 EY014104NEI NIH HHS R01 EY017841NEI NIH HHS R01 EY019126NEI NIH HHS R01 EY022305NEI NIH HHS R01 EY023242NEI NIH HHS R01 EY023512NEI NIH HHS R01 EY023646NEI NIH HHS R21 EY028671NIH HHS 1R01-EY023646NIH HHS 5P30-EY005722NIH HHS 5R01 EY019126NIH HHS KL2TR000440NIH HHS P30EY014104NIH HHS P30EY06360NIH HHS R01EY017841NIH HHS R01 EY022305NIH HHS S10 OD018164
6 · The paper itself

Abstract

Central corneal thickness (CCT) is one of the most heritable ocular traits and it is also a phenotypic risk factor for primary open angle glaucoma (POAG). The present study uses the BXD Recombinant Inbred (RI) strains to identify novel quantitative trait loci (QTLs) modulating CCT in the mouse with the potential of identifying a molecular link between CCT and risk of developing POAG. The BXD RI strain set was used to define mammalian genomic loci modulating CCT, with a total of 818 corneas measured from 61 BXD RI strains (between 60-100 days of age). The mice were anesthetized and the eyes were positioned in front of the lens of the Phoenix Micron IV Image-Guided OCT system or the Bioptigen OCT system. CCT data for each strain was averaged and used to QTLs modulating this phenotype using the bioinformatics tools on GeneNetwork (www.genenetwork.org). The candidate genes and genomic loci identified in the mouse were then directly compared with the summary data from a human POAG genome wide association study (NEIGHBORHOOD) to determine if any genomic elements modulating mouse CCT are also risk factors for POAG.This analysis revealed one significant QTL on Chr 13 and a suggestive QTL on Chr 7. The significant locus on Chr 13 (13 to 19 Mb) was examined further to define candidate genes modulating this eye phenotype. For the Chr 13 QTL in the mouse, only one gene in the region (Pou6f2) contained nonsynonymous SNPs. Of these five nonsynonymous SNPs in Pou6f2, two resulted in changes in the amino acid proline which could result in altered secondary structure affecting protein function. The 7 Mb region under the mouse Chr 13 peak distributes over 2 chromosomes in the human: Chr 1 and Chr 7. These genomic loci were examined in the NEIGHBORHOOD database to determine if they are potential risk factors for human glaucoma identified using meta-data from human GWAS. The top 50 hits all resided within one gene (POU6F2), with the highest significance level of p = 10-6 for SNP rs76319873. POU6F2 is found in retinal ganglion cells and in corneal limbal stem cells. To test the effect of POU6F2 on CCT we examined the corneas of a Pou6f2-null mice and the corneas were thinner than those of wild-type littermates. In addition, these POU6F2 RGCs die early in the DBA/2J model of glaucoma than most RGCs. Using a mouse genetic reference panel, we identified a transcription factor, Pou6f2, that modulates CCT in the mouse. POU6F2 is also found in a subset of retinal ganglion cells and these RGCs are sensitive to injury.

Indexed as

Genetic LociAnimalsApoptosisCells, CulturedChromosome MappingCorneaCorneal PachymetryDisease Models, AnimalEmbryo, MammalianFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyGlaucomaHumansMaleMicePOU6F2 protein, humanPou6f2 protein, mousePOU Domain Factors

Identifiers

PMID29370175
PMCPMC5784889
OpenAlexW2765361998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.